Hologic Inc
NASDAQ:HOLX

Watchlist Manager
Hologic Inc Logo
Hologic Inc
NASDAQ:HOLX
Watchlist
Price: 78.97 USD 0.32% Market Closed
Market Cap: 18.3B USD
Have any thoughts about
Hologic Inc?
Write Note

Hologic Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hologic Inc
Net Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Hologic Inc
NASDAQ:HOLX
Net Income
$789.5m
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
47%
Becton Dickinson and Co
NYSE:BDX
Net Income
$1.7B
CAGR 3-Years
-6%
CAGR 5-Years
7%
CAGR 10-Years
4%
Boston Scientific Corp
NYSE:BSX
Net Income
$1.8B
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Net Income
$3.6B
CAGR 3-Years
24%
CAGR 5-Years
1%
CAGR 10-Years
19%
Abbott Laboratories
NYSE:ABT
Net Income
$5.6B
CAGR 3-Years
-8%
CAGR 5-Years
11%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Net Income
$2.3B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
18%
No Stocks Found

Hologic Inc
Glance View

Market Cap
18.3B USD
Industry
Health Care

Hologic Inc. is a leading global medical technology company dedicated to improving women's health through innovative diagnostics, medical imaging, and surgical products. Founded in 1982, Hologic has carved out a niche in the healthcare sector, specifically focusing on areas such as breast health, cervical health, and skeletal health. The company’s flagship products include advanced breast imaging systems and molecular diagnostics, which enable early disease detection and improve patient outcomes. As awareness and demand for women's health services continue to grow, Hologic stands out as a key player, consistently investing in research and development to stay at the forefront of medical innovation. For investors, Hologic represents a promising opportunity with its robust portfolio and strategic positioning in expanding markets. The company has experienced significant growth, driven by its commitment to addressing critical health issues, particularly in breast cancer screening and gynecological diagnostics. With a track record of strong financial performance and a resilient business model, Hologic is poised to benefit from tailwinds in healthcare spending and increasing emphasis on preventive care. As societal shifts continue to favor healthcare advancements that prioritize women's health, Hologic's consistent revenue growth and strategic acquisitions create a compelling case for investment, establishing it as a company well equipped to thrive in an evolving marketplace.

HOLX Intrinsic Value
81.31 USD
Undervaluation 3%
Intrinsic Value
Price

See Also

What is Hologic Inc's Net Income?
Net Income
789.5m USD

Based on the financial report for Sep 28, 2024, Hologic Inc's Net Income amounts to 789.5m USD.

What is Hologic Inc's Net Income growth rate?
Net Income CAGR 10Y
47%

Over the last year, the Net Income growth was 73%. The average annual Net Income growth rates for Hologic Inc have been -25% over the past three years , and 47% over the past ten years .

Back to Top